Start an analysis for OPRX
OptimizeRx Corporation
Stock · NASDAQProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $10.0k | 30-Sep-26 | 10-Q filed 13-Nov-26 |
| Remaining authorization | $10.0kEST | 30-Sep-26 | 10-Q filed 13-Nov-26 |
| Program expiry | 15-Mar-27 | 30-Sep-26 | 10-Q filed 13-Nov-26 |
| Repurchased last quarter | Not found in filings | — | |
| Has used an ASR | No | — |
Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 05-Mar-26 | $10.0k | $10.0kEST | 15-Mar-27 | On March 5, 2026, the Company announced that its Board authorized the repurchase of up to $10,000 of the Company’s outstanding common stock.10-Q filed 13-Nov-26 |
Open-market repurchases
None reported in the filings we hold.